Journey Medical Net Worth
Journey Medical Net Worth Breakdown | DERM |
Journey Medical Net Worth Analysis
Journey Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Journey Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Journey Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Journey Medical's net worth analysis. One common approach is to calculate Journey Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Journey Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Journey Medical's net worth. This approach calculates the present value of Journey Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Journey Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Journey Medical's net worth. This involves comparing Journey Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Journey Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Journey Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Journey Medical's net worth research are outlined below:
| Journey Medical Corp had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 79.18 M. Net Loss for the year was (3.85 M) with profit before overhead, payroll, taxes, and interest of 42.89 M. | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: FY2024 EPS Forecast for Journey Medical Lowered by Analyst - MarketBeat |
Journey Medical Quarterly Good Will |
|
Journey Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Journey Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Journey Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Journey Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Journey Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Journey Medical Corp backward and forwards among themselves. Journey Medical's institutional investor refers to the entity that pools money to purchase Journey Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-06-30 | 51.9 K | Atria Investments Llc | 2024-09-30 | 44.4 K | Gladstone Institutional Advisory Llc | 2024-09-30 | 33.5 K | State Street Corp | 2024-06-30 | 25.6 K | Brighton Jones Llc | 2024-09-30 | 23 K | Perkins Capital Management Inc | 2024-09-30 | 22 K | Cetera Investment Advisers | 2024-06-30 | 18.6 K | Northern Trust Corp | 2024-09-30 | 17.7 K | Titleist Asset Management, Llc | 2024-09-30 | 14.2 K | Vanguard Group Inc | 2024-09-30 | 325.2 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 314.4 K |
Follow Journey Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 112.18 M.Market Cap |
|
Project Journey Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Capital Employed | (0.06) | (0.06) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.19) | (0.18) |
When accessing Journey Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Journey Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Journey Medical's profitability and make more informed investment decisions.
Evaluate Journey Medical's management efficiency
Journey Medical Corp has return on total asset (ROA) of (0.1733) % which means that it has lost $0.1733 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2958) %, meaning that it created substantial loss on money invested by shareholders. Journey Medical's management efficiency ratios could be used to measure how well Journey Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to drop to -0.07. In addition to that, Return On Capital Employed is likely to drop to -0.06. At this time, Journey Medical's Intangible Assets are very stable compared to the past year. As of the 25th of November 2024, Intangibles To Total Assets is likely to grow to 0.28, while Non Current Assets Total are likely to drop about 16.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.12 | 1.06 | |
| Enterprise Value Over EBITDA | 49.61 | 52.10 | |
| Price Book Value Ratio | 5.16 | 3.50 | |
| Enterprise Value Multiple | 49.61 | 52.10 | |
| Price Fair Value | 5.16 | 3.50 | |
| Enterprise Value | 95.3 M | 105.4 M |
The strategic initiatives led by Journey Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 1.8961 | Revenue 57.8 M | Quarterly Revenue Growth (0.58) | Revenue Per Share 2.921 | Return On Equity (1.30) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Journey Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Journey Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Journey Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Journey Medical Corporate Filings
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 13th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 1st of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 19th of July 2024 Other Reports | ViewVerify |
Journey Medical Earnings per Share Projection vs Actual
Journey Medical Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Robyn Hunter | Treasurer Sec | Profile | |
| Ernest Galvan | VP Strategy | Profile | |
| Joseph Benesch | Interim Controller | Profile | |
| Claude Maraoui | President, Founder | Profile | |
| Robert Nevin | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 2.921 | Quarterly Revenue Growth (0.58) | Return On Assets (0.17) | Return On Equity (1.30) |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.